ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results
PLEASANTON, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) — ProSomnus, Inc. (“the Company”) (NASDAQ: OSA), the leading non-CPAP Obstructive Sleep Apnea Therapy, today announced financial results for the third quarter ended September 30, 2023.
Related news for (OSA)
- Cosa Resources Announces Voting Results from Its Annual General Meeting
- Cosa Resources Enters into Option Agreement for the Astro Uranium Project, Athabasca Basin, Saskatchewan
- Global Uranium Enters Into Option Agreement With Cosa Resources for the Astro Uranium Project in the Athabasca Basin, Saskatchewan, Canada
- Cosa Resources Announces Drilling Plans for Murphy Lake North Uranium Project, Athabasca Basin, Saskatchewan
- Cosa Resources Reports Uranium Assays from the 100% Owned Ursa Project, Athabasca Basin, Saskatchewan